ADK and breast carcinoma: Selective knockout of ADK isoforms via CRISPR/Cas9-mediated approaches suppressed breast cancer cell migration and invasion, which with the elevation of a tumor-related enzyme, matrix metalloproteinases, and downregulation of cyclin D2 and THB1 (Shamloo et al., 2019).